2004
DOI: 10.1097/01.asn.0000142425.23036.ac
|View full text |Cite
|
Sign up to set email alerts
|

Selectin Inhibitor Bimosiamose Prolongs Survival of Kidney Allografts by Reduction in Intragraft Production of Cytokines and Chemokines

Abstract: Abstract. Binding of the P-, L-, and E-selectins to sialyl Lewis (CI Ͻ1 is synergistic; CI ϭ 1 is additive; and CI Ͼ1 is antagonistic). Similarly, BIMO interacted synergistically with sirolimus (CI ϭ 0.64) and FTY720 (CI ϭ 0.22). While the mechanism of immunosuppression was being analyzed, decreased infiltration of CD4 ϩ , CD8 ϩ , and macrophages on day 7 after grafting was observed. Multiple cytokines were also expressed, including IL-1␣, IL-1␤, IL-2, IL-4, IL-6, IL-10, IL-12, IL-18, TNF-␣, and IFN-␥ in kidne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
11
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(12 citation statements)
references
References 50 publications
(45 reference statements)
1
11
0
Order By: Relevance
“…Administration of a mAb against the proinflammatory cytokine IL-6 ameliorated structural and functional consequences of ischemic AKI, decreased neutrophil infiltration, and reduced proinflammatory cytokine production (171). Bimosiamose, a novel pan-selectin inhibitor, protected from ischemic AKI in a kidney transplant model by reducing infiltration of macrophages and T cells and inhibiting intragraft expression of chemokines and cytokines (172). In addition to cholesterol lowering in humans, widely used statins possess several properties that may be beneficial in ischemic AKI, including profound anti-inflammatory effects, inhibition of reactive oxygen species, and stimulation of endothelial NO production (173)(174)(175).…”
Section: Alterations In the Inflammatory Responsementioning
confidence: 99%
“…Administration of a mAb against the proinflammatory cytokine IL-6 ameliorated structural and functional consequences of ischemic AKI, decreased neutrophil infiltration, and reduced proinflammatory cytokine production (171). Bimosiamose, a novel pan-selectin inhibitor, protected from ischemic AKI in a kidney transplant model by reducing infiltration of macrophages and T cells and inhibiting intragraft expression of chemokines and cytokines (172). In addition to cholesterol lowering in humans, widely used statins possess several properties that may be beneficial in ischemic AKI, including profound anti-inflammatory effects, inhibition of reactive oxygen species, and stimulation of endothelial NO production (173)(174)(175).…”
Section: Alterations In the Inflammatory Responsementioning
confidence: 99%
“…In addition, HUVEC are isolated from large veins, while the endothelial inflammatory response associated with ischemia/reperfusion injury is most pronounced in the venular microvasculature (10). (4,(45)(46)(47) or adhesion molecule deficient animals (48,49). Inhibition of selectin function has reduced inflammation and fibrosis in a large animal model of warm and cold ischemia (46 (50,51), however, multicenter randomized trials did not confirm this effect (52); success being limited perhaps by the redundancy of adhesion molecule/leukocyte interactions in vivo (53,54 …”
Section: Leukocyte Recruitment To Hypoxia-stimulated Endothelial Cellmentioning
confidence: 99%
“…11 Treatment with the potent selectin antagonist bimosiamose was recently reported to inhibit rejection of kidney allografts in a rat model. 12 Because these strategies have indiscriminately targeted both donor and recipient selectins, specific contributions of either donor or recipient selectins in the process of allograft rejection remain to be elucidated. In this study, murine cardiac allografts were performed using mice deficient in all three selectins (ELP Ϫ/Ϫ ) as donor or recipient animals.…”
mentioning
confidence: 99%